Haegarda Now Available to HAE Patients Across Canada

Haegarda Now Available to HAE Patients Across Canada

294350

Haegarda Now Available to HAE Patients Across Canada

Haegarda is now available to adolescent and adult hereditary angioedema (HAE) patients across Canada for the prevention of HAE attacks, according to CSL Behring, the therapy’s developer. The company announced its preventive treatment, made available for eligible HAE patients in April, can now be given in all of Canada without any restrictions. It first became available to patients in the Canadian province of Quebec in February 2020. Following this announcement, HAE Canada, a Canadian patient…

You must be logged in to read/download the full post.